Scarica l'app Stockscreener
21.44
0.61%
0.07
Precedente Chiudi:
$21.37
Aprire:
$21.6
Volume 24 ore:
96,486
Relative Volume:
0.02
Capitalizzazione di mercato:
$5.01B
Reddito:
$330.24M
Utile/perdita netta:
$34.79M
Rapporto P/E:
-107.20
EPS:
-0.2
Flusso di cassa netto:
$66.12M
1 W Prestazione:
+6.44%
1M Prestazione:
+37.65%
6M Prestazione:
+123.97%
1 anno Prestazione:
+445.70%
Intervallo 1D:
$21.35
$21.70
Intervallo di 1 settimana:
$18.90
$21.70
Portata 52W:
$3.60
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Confronta ADMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ADMA | 21.49 | 5.01B | 330.24M | 34.79M | 66.12M | -0.20 |
| VRTX | 446.63 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.99 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.16 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.68 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.33 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
ADMA Biologics drops as auditor resigns - MSN
New Millennium Group LLC Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
First Turn Management LLC Acquires New Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
Wall Street Analysts See a 31.3% Upside in Adma Biologics (ADMA): Can the Stock Really Move This High? - Yahoo Finance
Oppenheimer & Co. Inc. Has $1.90 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
GSA Capital Partners LLP Sells 109,045 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - Zacks Investment Research
Statutory Profit Doesn't Reflect How Good ADMA Biologics' (NASDAQ:ADMA) Earnings Are - Yahoo Finance
Entropy Technologies LP Purchases Shares of 37,850 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
State of New Jersey Common Pension Fund D Has $2.27 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Janney Montgomery Scott LLC Takes Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
29,143 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Acquired by Aigen Investment Management LP - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Stake Raised by Amalgamated Bank - MarketBeat
Principal Financial Group Inc. Has $23.87 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Los Angeles Capital Management LLC Acquires 67,740 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
ADMA Biologics Inc (ADMA) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Mesirow Financial Investment Management Inc. Sells 30,105 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Stock Traders Buy Large Volume of ADMA Biologics Call Options (NASDAQ:ADMA) - MarketBeat
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Lisanti Capital Growth LLC Takes $4.70 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
HC Wainwright Predicts Increased Earnings for ADMA Biologics - MarketBeat
HC Wainwright Issues Positive Forecast for ADMA Biologics (NASDAQ:ADMA) Stock Price - MarketBeat
Earnings Beat: Here's What ADMA Biologics, Inc. (NASDAQ:ADMA) Analysts Are Forecasting For Next Year - Yahoo Finance
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript - Insider Monkey
Kirby McInerney LLP Reminds ADMA Biologics, Inc. (ADMA) Investors of Shareholder Investigation - WICZ
Robeco Institutional Asset Management B.V. Purchases 68,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
New York State Teachers Retirement System Purchases New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Earnings call: ADMA Biologics reports robust growth, raises guidance - Investing.com India
ADMA Biologics stock soars to all-time high of $21.25 By Investing.com - Investing.com South Africa
ADMA Biologics (NASDAQ:ADMA) Stock Price Expected to Rise, Raymond James Analyst Says - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week HighWhat's Next? - MarketBeat
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
ADMA Biologics stock soars to all-time high of $21.25 - Investing.com
ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses - GlobeNewswire
Adma Biologics: Q3 Earnings Snapshot - CTPost
ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Reco - GuruFocus.com
ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge - Yahoo Finance
ADMA Biologics, Inc. Revises Earnings Guidance for the Fiscal Year 2024-2025 - Marketscreener.com
ADMA Biologics Reports Robust Q3 2024 Growth - TipRanks
ADMA Biologics Inc earnings beat by $0.02, revenue topped estimates - Investing.com
ADMA Biologics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance UK
ADMA Biologics Inc Reports Q3 2024 Revenue of $119.8 Million, Su - GuruFocus.com
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Did ADMA Biologics (ADMA) Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Investigation - AccessWire
3 High Growth Tech Stocks Leading The US Market - Yahoo Finance
ADMA STOCK ALERT: Why is ADMA Biologics Under Investigation for Securities Fraud? Contact BFA Law if You Lost Money on Your Investment (Nasdaq:ADMA) - AccessWire
ADMA Biologics Inc (ADMA) Q3 2024: Everything You Need To Know A - GuruFocus.com
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):